Stefan Linn

Stefan Linn General Information

Biography

Mr. Stefan Linn serves as Chief Executive Officer and Managing Partner at L1 Health. He serves as Board Member at Sun Wave Pharma.He serves as Chairman at Destination Pet. Prior to joining LetterOne, he was Chief Operating Officer of Oxford Immunotec, a NASDAQ-traded diagnostics company focused on immune-related conditions and responsible for global commercial operations, manufacturing, supply chain and product development. Before joining Oxford Immunotec, he was a member of the senior executive team at IMS Health (now IQVIA) in a variety of roles to advance the company's transformation following its take-private by TPG, including strategy, acquisitions, commercial operations and global product development. He joined IMS Health from TPG Capital, a leading private investment firm, where he evaluated the operating potential of new investments and worked with TPG's operating companies to drive operating improvements. Previous to that, he held senior positions at McKesson Corporation, responsible for marketing and product development, as well as its direct-to-patient business McKesson Patient Relationship Solutions, the packaging operation RxPack and the pharmacy franchise Health Mart. Earlier in his career, he worked at Merck-Medco and was a founding executive of its System division. He also worked for McKinsey & Company in Europe and the U.S. He earned his bachelor's degree in Economics from the University of Dallas and his Master of Business Administration from the University of California at Berkeley.